Problem |
Adopting stakeholders’ perceptions of the urgency of the problem and its economic and other burdens |
|
Atun et al.’s framework |
Intervention |
Adopting stakeholders’ perceptions of intervention complexity, relative advantage, and cost |
|
Atun et al.’s framework |
Adopting system |
Stakeholders who decide whether to adopt and the distribution of decision-making power among them |
To what extent do you think other providers you work with screen for abnormal blood glucose according the guideline? To what extent do you think that other providers you work with refer to or provide intensive behavioral counseling to patients with prediabetes?
To what extent do others you work with support you following this recommendation?
To what extent do you feel under pressure from anyone to do this? Or not to do it?
|
Atun et al.’s framework |
Health system charateristics |
Regulatory, organizational, and financial factors that constrain or support intervention adoption |
|
Atun, et al.’s framework |
Context |
Interplay of demographic, economic, socio-cultural, and technological factors in the broader community |
|
Atun et al.’s framework |
Environment |
Organizational resources and physical, political and economic factors |
|
Andersen’ s behavioral model |
Evaluated need |
Professional judgement about people’s health status and their need for medical care |
|
Andersen’ s behavioral model |
Predisposing demographics |
Socio-demographic predispositions such as race, gender, age |
|
Andersen’ s behavioral model |
Enabling resources |
Factors SUCH as health insurance coverage, health system reimbursement and incentives or other factors that support intervention use |
|
Andersen’ s behavioral model |
Awareness |
Providers’ awareness of any clinical guideline related to diabetes prevention and specifically the 2015 USPSTF abnormal blood glucose recommendation |
There are several diabetes-related screening guideline recommendations. Now I would like to ask you about your views of a specific practice guideline recommendation. In late 2015, the USPSTF revised their abnormal blood glucose guidelines, how familiar are you with this recommendation? Can you tell me about this recommendation?
|
Awareness-to-adherence model |
Agreement |
Providers’ agreement (or disagreement) with published clinical guidelines for diabetes screening and prediabetes treatment |
|
Awareness-to-adherence model |
Adoption |
The extent to which providers follow the guideline/recommendation in their clinical practice |
|
Awareness-to-adherence model |
Adherence |
The extent to which providers succeed in adhering to it (or follow it consistently at appropriate times). |
To what extent would you say, as a percentage, you adhere to the screening part of the recommendation? How about the prediabetes treatment recommendations?
What is your sense of strategies that could be used to increase the proportion of clinicians in the UNC health system who adhere to these recommendations regularly?
|
Awareness-to-adherence model |